A genetically engineered Escherichia coli for producing blue-colored bacteria and its construction and application

By constructing the E. coli genetically engineered strain IN05, the problems of low yield and low conversion rate of microbial fermentation production were solved, and high yield and high conversion rate of blue production were achieved, which reduced production costs and promoted its industrial application.

CN118028197BActive Publication Date: 2024-12-03VERTEXYN (NANJING) BIOWORKS CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410135824.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-31
Publication Date
2024-12-03
Estimated Expiration
2044-01-31

AI Technical Summary

Technical Problem

The existing microbial fermentation production has low yield, slow production speed and low conversion rate, resulting in high cost, and the need to add a variety of antibiotics and high growth pressure, which limits its industrial application.

Method used

By constructing E. coli genetically engineered strain IN05, knocking out the lactate dehydrogenase ldhA, glutamate-5-kinase proB and pyruvate kinase pykF genes, integrating phosphopanthionylethylamine transferase entD and point mutation glutamine Synthetic enzyme glnA* reduces the shunt of pyruvate and glutamate, improves the expression intensity of guanlan synthase, and only a single antibiotic-induced culture is required.

Benefits of technology

The production of Guanlan has been significantly improved to 10.25g/L, which has reduced production costs, reduced plasmid number, increased conversion rate, reduced growth pressure, and promoted the feasibility of industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118028197B_ABST
    Figure CN118028197B_ABST
Patent Text Reader

Abstract

The present invention relates to the field of biotechnology, and in particular to a genetically engineered Escherichia coli for producing indigofera and its construction and application. The genetically engineered Escherichia coli is constructed by introducing the expression vector pRk-bpsA into a chassis strain; the chassis strain is a strain IN05 that is genetically modified, and the genetic modification includes knocking out the lactate dehydrogenase ldhA gene, the glutamate-5-kinase proB gene, and the pyruvate kinase pykF gene, and integrating the phosphopantetheine transferase entD gene and the glutamine synthetase glnA* gene through point mutation into a specific site to construct. The genetically engineered strain of the present invention uses glucose as a substrate to generate a large amount of glutamine in vivo for synthesizing indigofera, which can reduce the use of antibiotics, improve conversion rate, reduce production costs, and is green and environmentally friendly, and can further promote the process of industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biotechnology, and in particular to a genetically engineered Escherichia coli bacterium for producing blue-green aloe vera and its construction and application. Background Art

[0002] Blue is a natural blue pigment with no toxic side effects, mainly used in the dye industry. Blue synthetase is a non-ribosomal peptide synthetase, which is activated by 4'-phosphopantetheinyl transferase to synthesize 2 molecules of glutamine in microorganisms into 1 molecule of blue. Blue is a water-insoluble blue pigment that can be dissolved in a few organic solvents, such as DMF, DMSO, tetrahydrofuran, pyridine, N-methylpyrrolidone, etc. It can also be reduced to a leuco form by sodium dithionite.

[0003] Pigments are divided into natural pigments and synthetic pigments. Synthetic pigments have the advantages of bright color, rich variety, high production output, cost and low price relative to natural pigments. However, since most of the raw materials used in its synthesis process are toxic compounds, a large amount of use is not only easy to poison, carcinogenic, and allergic, and the synthetic pigment itself is difficult to degrade, and the industrial wastewater is highly toxic, difficult to degrade, and the chromaticity value is high, causing serious environmental pollution problems. Therefore, the production of blue pigment by microbial fermentation has little pollution and low cost, and has gradually become an alternative to industrial synthetic pigments. However, the production of blue pigment by microbial fermentation in the industry is relatively low, the production speed is slow, and the conversion rate is low. The problem leads to high cost, and there is still a distance from large-scale industrial production and application. The previous generation strain constructed by our company has solved some of the shortcomings, but there are still many plasmid expression genes, and it is necessary to add many types of antibiotics, and the strain growth pressure is large, and the conversion rate is low. Problems. In view of the problems existing in the above-mentioned prior art, the present invention discloses a kind of Escherichia coli genetic engineering bacteria for producing blue pigment and construction method and application, which does not need to add multiple antibiotics, has low growth pressure, high yield, and high conversion rate, and has the potential to accelerate the realization of industrial application. Summary of the invention

[0004] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a genetically engineered Escherichia coli for producing blue, a construction method and an application thereof, which has a high conversion rate, a fast production speed and the potential to accelerate the realization of industrial applications.

[0005] To achieve the above object, the technical solution adopted by the present invention is:

[0006] In the first aspect, the present invention provides a genetically engineered Escherichia coli for producing blue, characterized in that the genetically engineered Escherichia coli is constructed by introducing an expression vector pRk-bpsA into a chassis strain; the expression vector pRk-bpsA is constructed by using pRK-bpsA-entD as a plasmid template, amplifying the bpsA fragment and the pRK plasmid skeleton by primer PCR respectively, and then connecting the bpsA fragment with the pRK plasmid skeleton; the chassis strain is strain IN05 that has been genetically modified, and the genetic modification includes The lactate dehydrogenase ldhA gene, the glutamate-5-kinase proB gene, and the pyruvate kinase pykF gene are knocked out, and then the phosphopantetheinyl transferase entD gene is integrated into the sites of the knocked-out lactate dehydrogenase ldhA gene and the glutamate-5-kinase proB gene, and the glutamine synthetase glnA* gene with a point mutation is integrated into the site of the knocked-out pyruvate kinase pykF gene; the glutamine synthetase glnA* gene with a point mutation is a mutation in the amino acid Y at position 405 of the glutamine synthetase glnA gene.

[0007] Bacterial strain IN05 is the IN05 strain that our company has previously constructed, and its construction method is detailed in patent document CN116064363B. The present invention is used to produce the genetically engineered Escherichia coli bacteria of viewing blue, with genetically engineered strain IN05 as the starting strain, by reducing the shunt of pyruvic acid to strengthen the flux of tricarboxylic acid cycle (ΔldhA, ΔpykF), while reducing the shunt of glutamate to promote the flux of glutamate to glutamine (ΔproB), and further integrate the gene on the plasmid into the genome by the method of gene editing (entD and glnA, J23119 is a strong constitutive promoter, which can improve the entD gene expression intensity), to release the growth pressure brought by the expression plasmid to the strain, and by screening glutamine synthase for point mutations, further strengthen the intensity of glutamate to generate glutamine, provide sufficient substrate for the synthesis of viewing blue, and improve conversion efficiency. It also reduces the number of plasmids (only carrying a single plasmid to express the key gene blue pigment synthase bpsA), and only a single antibiotic needs to be added to induce culture. The metabolic pathway of the genetically engineered Escherichia coli used to produce blue in the present invention is shown in FIG. Figure 1 shown.

[0008] Preferably, the glutamine synthetase glnA* gene subjected to point mutation comprises mutating the 405th amino acid Y of the glutamine synthetase glnA gene to any one of A, E, and F.

[0009] The present invention improves the activity of glutamine synthetase by performing point mutation screening on glutamine synthetase, further strengthens the intensity of glutamate generating glutamine, provides sufficient substrate for the synthesis of indigo plant, and improves the conversion efficiency.

[0010] More preferably, the glutamine synthetase glnA* gene that has undergone point mutation is a mutation of the 405th amino acid Y of the glutamine synthetase glnA gene to F.

[0011] The genetically engineered bacteria obtained by constructing the above-mentioned specific site-directed mutations are used to produce indigo blue, and the final yield can reach 10.25 g / L, which is the highest level of indigo blue production in the Escherichia coli system at present.

[0012] Preferably, the entD gene is first linked to the strong constitutive promoter J23119 before integration.

[0013] In a second aspect, the present invention provides a method for constructing the above-mentioned genetically engineered Escherichia coli for producing blue, comprising the following steps:

[0014] (1) Based on strain IN05, the ldhA gene was knocked out using CRISPR-Cas9, and a strong constitutive promoter J23119-entD was introduced into the gene locus, named strain IN06;

[0015] (2) Based on strain IN06, the proB gene was knocked out using CRISPR-Cas9, and a strong constitutive promoter J23119-entD was introduced into the gene locus, named strain IN07;

[0016] (3) The glutamine synthetase glnA gene was amplified by PCR to introduce point mutations, and the gene fragments of glutamine synthetase glnA* with different mutations were obtained; 95S was used as a plasmid template, and the gene fragment glutamine synthetase glnA* was connected with the 95S linearized fragment to obtain 95S-glnA*; a strong constitutive promoter J23119-glnA* was introduced into the gene site; and the point mutation gene fragment J23119-glnA* was amplified with primers;

[0017] (4) Based on strain IN07, the pykF gene was knocked out using CRISPR-Cas9, and the point mutation gene fragment J23119-glnA* obtained in step (3) was introduced into the gene site to obtain a chassis strain modified by point mutation;

[0018] (5) Construction of expression vector pRK-bpsA: Using pRK-bpsA-entD plasmid as template, amplify the blue pigment synthase bpsA fragment and the pRK plasmid backbone by primer PCR, and then connect the bpsA fragment to the pRK plasmid backbone to obtain the expression vector pRK-bpsA;

[0019] (6) The expression vector pRK-bpsA is transferred into the chassis strain obtained in step (4) after point mutation modification to construct an expression strain, thereby obtaining the genetically engineered Escherichia coli bacteria for producing blue.

[0020] In a third aspect, the present invention provides the use of the above-mentioned genetically engineered Escherichia coli for producing indigo in the production of indigo.

[0021] The invention knocks out or in situ mutates the gene of the metabolic roadbed of Escherichia coli using pyruvate as a carbon source and energy, so as to enhance central metabolism and promote post-translational modification of key proteins; then, the flux of the tricarboxylic acid cycle is enhanced by reducing the shunt of pyruvate, and the flux of glutamate to glutamine is enhanced by reducing the shunt of glutamate, and then the gene on the plasmid is further integrated into the genome by a gene editing method to release the growth pressure brought by the expression plasmid to the strain, and the intensity of glutamine generation from glutamate is further enhanced by performing point mutation screening on glutamine synthase, so as to provide sufficient substrate for the synthesis of indigofera, so as to improve the conversion efficiency.

[0022] Preferably, the production method is fermentation culture.

[0023] In a fourth aspect, the present invention provides a method for producing indigofera by the genetically engineered Escherichia coli used to produce indigofera, comprising the following steps: inoculating the genetically engineered Escherichia coli used to produce indigofera into a fermentation medium, adding antibiotics, and inducing culture to obtain a fermentation broth containing indigofera.

[0024] Preferably, the inoculation amount of the genetically engineered Escherichia coli is 1-10%.

[0025] More preferably, the inoculation amount of the genetically engineered Escherichia coli is 1%.

[0026] Preferably, the fermentation medium is ZYM medium; and the antibiotic is kanamycin.

[0027] The final concentration of kanamycin in the culture medium is 50 μg / mL.

[0028] Preferably, the induction culture conditions are: temperature of 20-30°C, rotation speed of 180-225 rpm, and induction expression for 16-24 hours.

[0029] The formula of ZYM fermentation medium is: tryptone 10g / L, yeast powder 5g / L, Na 2 HPO 4 3.55g / L, KH 2 PO 4 3.4 g / L, NH 4 Cl 1.2~2.5g / L, Na 2 SO4 0.71g / L, MgSO 4 7H 2 O 0.5g / L, 100*trace elements 10mL / L, glycerol 0.5% (wt), glucose 0.5g / L, L-arabinose 1~2.8g / L.

[0030] Among them, the formula of 100*trace elements (100* means that the mother solution concentration is 100 times the final working concentration) is: CuSO 4 0.32g / L, CaCl 2 ·2H 2 O 1.5~3.1g / L, MnCl 2 ·4H 2 O 0.32g / L, ZnSO 4 7H 2 O 5.75g / L, CoCl 2 6H 2 O 0.47g / L, FeSO 4 7H 2 O 2.8g / L, Na 2 MO 4 ·2H 2 O 0.48g / L, 0.5MEDTA 80mL / L.

[0031] The beneficial effects of the present invention are:

[0032] 1. The genetically engineered Escherichia coli bacteria for producing indigofera of the present invention uses the genetically engineered strain IN05 as the starting strain, strengthens the flux of the tricarboxylic acid cycle by reducing the shunt of pyruvate (knocked out pykF and ldhA), and simultaneously reduces the shunt of glutamate to increase the flux of glutamate to glutamine (knocked out proB), and further integrates the genes on the plasmid into the genome by a gene editing method (entD and glnA, J23119 is a strong constitutive promoter, which can improve the expression intensity of the entD gene) to release the growth pressure brought by the expression plasmid to the strain, and further strengthens the intensity of glutamine generation from glutamate by performing point mutation screening on glutamine synthase, thereby providing sufficient substrate for the synthesis of indigofera, improving the conversion efficiency, and significantly improving the indigofera yield relative to previous strains.

[0033] 2. The strain constructed in patent document CN116064363B carries two plasmids pRK-bpsA-entD and 95S-glnA, and needs to add two antibiotics; the genetically engineered Escherichia coli of the present invention reduces the number of plasmids) and only carries a single plasmid to express the key gene cyanidin synthase bpsA), and only a single antibiotic needs to be added for induced culture.

[0034] 3. The genetically engineered strain of the present invention has a high conversion rate, reduces production costs, is environmentally friendly, and can further promote the process of industrial production. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 This is a metabolic pathway diagram of the genetically engineered Escherichia coli used to produce blue indigo according to the present invention.

[0036] Figure 2 This is a comparison chart of the yield of genetically engineered Escherichia coli used to produce blue. DETAILED DESCRIPTION

[0037] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.

[0038] The formula of the LB culture medium of the present invention is: 10g / L sodium chloride, 10g / L peptone, and 5g / L yeast extract.

[0039] The genetically engineered Escherichia coli bacteria producing blue obtained in Example 3 of the present invention have been deposited in the China Center for Type Culture Collection on January 11, 2024, address: Wuhan University, Wuhan, China, with a deposit number of CCTCCNO: M 2024075 and a classification name of Escherichia coli IN11.

[0040] Example 1

[0041] An embodiment of the genetically engineered Escherichia coli for producing blue indigo in the present invention. The genetically engineered Escherichia coli in this embodiment is constructed by introducing the expression vector pRk-bpsA into the chassis strain IN08.

[0042] The method for constructing the genetically engineered Escherichia coli comprises the following steps:

[0043] 1. Construction of strain IN06

[0044] (1) Construction of pTarget-ldhA: Using pTargetF as a template, PCR amplification was performed using primers pTarget-ldhA-F and pTarget-ldhA-R, the template was digested with DpnⅠ, and transformed into DH5α to obtain pTarget-ldhA;

[0045] (2) Construction of 95S-entD: Using the Corynebacterium glutamicum pRK-bpsA-entD as a template, 95S-entD-F and 95S-entD-R primers were used to amplify the 95S-entD linearized fragment by PCR; using the 95S-rhtA plasmid as a template, 95S-F and 95S-R primers were used to amplify the 95S plasmid backbone by PCR; the 95S plasmid backbone and 95S-entD linearized fragment were assembled by Gibson, and then transformed into DH5α to obtain the plasmid 95S-entD;

[0046] (3) Construction of ΔldhA::entD donor fusion fragment: Using E. coli BW25113 as a template, ldhA-up800F and ldhA::entD-up500R primers were used to amplify the ΔldhA::entD up fragment by PCR; Using E. coli BW25113 as a template, ldhA::entD-down500F and ldhA-down800R primers were used to amplify the ΔldhA::entD down fragment by PCR; Using 95S-entD as a template, T5 / tac / 119-F1 and rrnB-R1-T1 primers were used to amplify the J23119-entD fragment by PCR; Using the ΔldhA::entD up fragment, ΔldhA::entD down fragment and J23119-entD fragment as templates, ldhA-up500F and ldhA-down500R primers were used to amplify the ΔldhA::entD down fragment by overlap extension PCR donor fusion fragment;

[0047] (4) The pTarget-ldhA and ΔldhA::entD donor fusion fragments were integrated into strain IN05 by electroporation, and then the strains with correct homologous recombination were screened by colony PCR to obtain the strain IN06.

[0048] 2. Construction of strain IN07

[0049] (1) Construction of pTarget-proB: Using pTargetF as a template, PCR amplification was performed using primers pTarget-proB-F and pTarget-proB-R, the template was digested with DpnⅠ, and transformed into DH5α to obtain pTarget-proB;

[0050] (2) Construction of ΔproB::entD donor fusion fragment: Using E. coli BW25113 as a template, using proB-up800F and proB::entD-up500R primers to amplify the ΔproB::entD up fragment by PCR; Using E. coli BW25113 as a template, using proB::entD-down500F and proB-down800R primers to amplify the ΔproB::entD down fragment by PCR; Using the ΔproB::entD up fragment, the ΔproB::entD down fragment and the J23119-entD fragment in Comparative Example 1 as templates, using proB-up500F and proB-down500R primers to perform overlap extension PCR amplification to obtain the ΔproB::entDdonor fusion fragment;

[0051] (3) The pTarget-proB and ΔproB::entD donor fusion fragments were integrated into strain IN06 by electroporation, and then the strains with correct homologous recombination were screened by colony PCR to obtain the strain IN07.

[0052] 3. Construction of chassis strain IN08

[0053] (1) Construction of pTarget-pykF: Using pTarget-ldhA as a template, PCR amplification was performed using primers pTarget-pykF-F and pTarget-pykF-R, the template was digested with DpnⅠ, and transformed into DH5α to obtain pTarget-pykF;

[0054] (2) Construction of 95S-glnA Y405A :Using Escherichia coli BW25113 as template, using glnA*-95S-F and glnA Y405A glnA was amplified by PCR with -R primers Y405A Upstream fragment, using glnA Y405A glnA was amplified by PCR using primers -F and glnA*-95S-R Y405A Downstream fragments; 95S plasmid backbone, glnA assembled by Gibson Y405A The upstream and downstream fragments were transformed into DH5α to obtain 95S-glnA Y405A ;

[0055] (3) Construction of ΔpykF::glnA Y405A Donor fusion fragment: ΔpykF::glnA was obtained by PCR amplification using E. coli BW25113 as a template using primers pykF-up800F and pykF::glnA-up500R.Y405A coli BW25113 as a template, and PCR amplification using pykF::glnA-down500F and pykF-down800R primers to obtain ΔpykF::glnA Y405A down fragment; 95S-glnA Y405A As a template, T5 / tac / 119-F1 and rrnB-R1 primers were used to amplify J23119-glnA Y405A fragment; ΔpykF::glnA Y405A up fragment, ΔpykF::glnA Y405A down fragment and J23119-glnA Y405A The fragment was used as a template and ΔpykF::glnA was obtained by overlapping extension PCR amplification using primers pykF-up500F and pykF-down500R. Y405A donor fusion fragment;

[0056] (4) Transform pTarget-pykF, ΔpykF::glnA by electroporation Y405A The donor fusion fragment was integrated into strain IN07, and then the strain with correct homologous recombination was screened by colony PCR to obtain the chassis strain IN08.

[0057] 4. Construction of the genetically engineered Escherichia coli described in this example:

[0058] (1) Construction of pRK-bpsA: Using pRK-bpsA-entD plasmid as a template, bpsA-pRk-F and bpsA-pRk-R primers were used to PCR amplify the bpsA fragment with homology arms; using pRK-bpsA-entD plasmid as a template, pRK-vector-F and pRK-vector-R primers were used to PCR amplify the pRK plasmid backbone; bpsA and pRK plasmid backbones were assembled by Gibson, and transformed into DH5α to obtain pRK-bpsA;

[0059] (2) pRK-bpsA was integrated into the chassis strain IN08 by electroporation to obtain the genetically engineered Escherichia coli.

[0060] In step (1), the specific process of the transformation is as follows: the mixed system is added to the DH5α transformation competent medium melted on ice, ice bathed for 30 minutes, heat shocked at 42°C for 1 minute, ice bathed again for 2 minutes, then 900uL of pre-cooled LB is added, and incubated at 37°C, 220rpm for 60 minutes; 100μL of the incubated bacterial solution is added to LB medium containing streptomycin resistance, and cultured at 37°C overnight.

[0061] In step (4), the specific process of the electroporation transformation is as follows: take 200ng of pTarget-ldhA and 400ng of ΔldhA::entD donor fusion fragment and add them to the prepared IN06 electroporation competent cells, gently mix them evenly and add them to the electroporation cup, and bathe them on ice for 5-10min; after 2.5KV electroporation, quickly add pre-cooled LB culture medium; then place the transformation liquid in a 30℃ shaker and incubate for 2 hours; after the incubation, take 100μL of the transformation liquid and spread it on the LB plate, and place it in a 30℃ incubator and culture it for 24h.

[0062] The primers used in this example are shown in Table 1-3.

[0063] Table 1 Primers for constructing strain IN06

[0064]

[0065]

[0066] Table 2 Primers for constructing strain IN07

[0067]

[0068]

[0069] Table 3 Primers for constructing chassis strain IN08

[0070]

[0071] Example 2

[0072] An embodiment of the genetically engineered Escherichia coli for producing blue indigo in the present invention. The genetically engineered Escherichia coli in this embodiment is constructed by introducing the expression vector pRk-bpsA into the chassis strain IN09.

[0073] The method for constructing the genetically engineered Escherichia coli comprises the following steps:

[0074] (1) The construction method of pTarget-pykF is the same as that of Example 1;

[0075] (2) Construction of 95S-glnA Y405E :Using Escherichia coli BW25113 as template, using glnA*-95S-F and glnA Y405E glnA was amplified by PCR with -R primers Y405E Upstream fragment, using glnA Y405E glnA was amplified by PCR using primers -F and glnA*-95S-R Y405EDownstream fragments; 95S plasmid backbone, glnA by Gibson assembly Y405E The upstream and downstream fragments were transformed into DH5α to obtain 95S-glnA Y405E ;

[0076] (3) Construction of ΔpykF::glnA Y405E Donor fusion fragment: ΔpykF::glnA was obtained by PCR amplification using E. coli BW25113 as a template using primers pykF-up800F and pykF::glnA-up500R. Y405E coli BW25113 as a template, and PCR amplification using pykF::glnA-down500F and pykF-down800R primers to obtain ΔpykF::glnA Y405E down fragment; 95S-glnA Y405E As a template, T5 / tac / 119-F1 and rrnB-R1 primers were used to amplify J23119-glnA Y405E fragment; ΔpykF::glnA Y405E up fragment, ΔpykF::glnA Y405E down fragment and J23119-glnA Y405E The fragment was used as a template and ΔpykF::glnA was obtained by overlapping extension PCR amplification using primers pykF-up500F and pykF-down500R. Y405E donor fusion fragment;

[0077] (4) Transform pTarget-pykF, ΔpykF::glnA by electroporation Y405E The donor fusion fragment was integrated into the strain IN07, and then the strain with correct homologous recombination was screened by colony PCR to obtain the chassis strain IN09;

[0078] (5) The construction method of pRK-bpsA is the same as that of Example 1;

[0079] (6) Integrate pRK-bpsA into the chassis strain IN09 by electroporation to obtain the genetically engineered Escherichia coli.

[0080] The relevant primers used in this example are shown in Table 4.

[0081] Table 4 Primers for constructing chassis strain IN09

[0082] Primer name Sequence (5'-3') <![CDATA[glnA Y405E -F]]> CCGCCAGAAGAAGAAAAAGAGATCCCAC <![CDATA[glnA Y405E -R]]> GTGGGATCTCTTTTTCTTCTTCTGGCGG

[0083] Example 3

[0084] An embodiment of the genetically engineered Escherichia coli for producing blue indigo in the present invention. The genetically engineered Escherichia coli in this embodiment is constructed by introducing the expression vector pRk-bpsA into the chassis strain IN10.

[0085] The method for constructing the genetically engineered Escherichia coli comprises the following steps:

[0086] (1) The construction method of pTarget-pykF is the same as that of Example 1;

[0087] (2) Construction of 95S-glnA Y405F :Using Escherichia coli BW25113 as template, using glnA*-95S-F and glnA Y405F glnA was amplified by PCR with -R primers Y405F Upstream fragment, using glnA Y405F glnA was amplified by PCR using primers -F and glnA*-95S-R Y405F Downstream fragments; 95S plasmid backbone, glnA by Gibson assembly Y405F The upstream and downstream fragments were transformed into DH5α to obtain 95S-glnA Y405F ;

[0088] (3) Construction of ΔpykF::glnA Y405F Donor fusion fragment: ΔpykF::glnA was obtained by PCR amplification using E. coli BW25113 as a template using primers pykF-up800F and pykF::glnA-up500R. Y405F coli BW25113 as a template, and PCR amplification using pykF::glnA-down500F and pykF-down800R primers to obtain ΔpykF::glnA Y405F down fragment; 95S-glnA Y405F As a template, T5 / tac / 119-F1 and rrnB-R1 primers were used to amplify J23119-glnA Y405F fragment; ΔpykF::glnA Y405F up fragment, ΔpykF::glnA Y405F down fragment and J23119-glnA Y405F The fragment was used as a template and ΔpykF::glnA was obtained by overlapping extension PCR amplification using primers pykF-up500F and pykF-down500R. Y405F donor fusion fragment;

[0089] (4) Transform pTarget-pykF, ΔpykF::glnA by electroporation Y405F The donor fusion fragment was integrated into the strain IN07, and then the strain with correct homologous recombination was screened by colony PCR to obtain the chassis strain IN10;

[0090] (5) The construction method of pRK-bpsA is the same as that of Example 1;

[0091] (6) pRK-bpsA was integrated into the chassis strain IN10 by electroporation to obtain the genetically engineered Escherichia coli.

[0092] The primers used in this example are shown in Table 5.

[0093] Table 5 Primers for constructing chassis strain IN10

[0094]

[0095] Comparative Example 1

[0096] A comparative example of the genetically engineered Escherichia coli bacteria for producing blue indigo in the present invention. The genetically engineered Escherichia coli bacteria in this comparative example are constructed by introducing the expression vector pRk-bpsA into strain IN05; the construction method of strain IN05 is detailed in patent document CN116064363B.

[0097] Comparative Example 2

[0098] A comparative example of the genetically engineered Escherichia coli bacteria for producing blue indigo according to the present invention. The genetically engineered Escherichia coli bacteria in this comparative example are constructed by introducing the expression vector pRk-bpsA into the strain IN06.

[0099] The method for constructing the genetically engineered Escherichia coli comprises the following steps:

[0100] (1) The construction method of pRK-bpsA is the same as that of Example 1;

[0101] (2) pRK-bpsA was integrated into the strain IN06 constructed in Example 1 by electroporation to obtain the genetically engineered Escherichia coli.

[0102] Comparative Example 3

[0103] A comparative example of the genetically engineered Escherichia coli bacteria for producing blue indigo according to the present invention. The genetically engineered Escherichia coli bacteria in this comparative example are constructed by introducing the expression vector pRk-bpsA into the strain IN07.

[0104] The method for constructing the genetically engineered Escherichia coli comprises the following steps:

[0105] The construction method of strain IN07, using the principle of CRISPR-Cas9 technology, is as follows:

[0106] (1) The construction method of pRK-bpsA is the same as that of Example 1;

[0107] (2) pRK-bpsA was integrated into the strain IN07 constructed in Example 1 by electroporation to obtain the genetically engineered Escherichia coli.

[0108] Test Example 1

[0109] The production of indigo by shake flask fermentation using genetically engineered Escherichia coli is as follows:

[0110] The genetically engineered Escherichia coli prepared in Activation Example 1-3 and Comparative Example 1-3 were inoculated into 50 mL of shake flask medium at a 1% inoculation rate for culture. The shake flask medium was ZYM medium, and kanamycin with a final concentration of 50 μg / mL was added to the medium. When the final concentration of glucose was 4 mg / L, induction was performed in a shaker at a temperature of 20-30°C and a rotation speed of 180-225 rpm. The expression was induced for 16-24 hours. After the induction, a blue shake flask culture solution was obtained. The sample was centrifuged and dissolved with DMSO, detected by a spectrophotometer, and brought into the standard curve for calculation.

[0111] The standard curve of indigo blue was determined by ultraviolet spectrophotometer. 1, 2, 3...16, 17, 18 μg of indigo blue standard was respectively taken in 1 mL DMSO, and the corresponding OD value was measured at 612 nm by spectrophotometer after ultrasonic dissolution. After recording, the standard curve was fitted with the horizontal axis representing concentration and the vertical axis representing OD value: Y=0.0694X+0.0087, R 2 =0.999 (correlation coefficient).

[0112] The final blue yield results of shake flask fermentation are shown in Table 6 and Figure 2 shown.

[0113] Table 6

[0114] Example Blue yield (g / L) Example 1 8.73 Example 2 7.96 Example 3 10.25 Comparative Example 1 3.23 Comparative Example 2 5.75 Comparative Example 3 7.15

[0115] The above results show that the present invention successfully constructs a genetically engineered Escherichia coli for producing blue pigment through genetic engineering modification. The genetically engineered strain of the present invention knocks out pykF and ldhA to allow more pyruvate to enter the tricarboxylic acid cycle, and knocks out proB to allow as much glutamate as possible to flow to the synthesis of glutamine. The number of plasmids is reduced, and only a single plasmid is carried to express the key gene blue pigment synthase bpsA, and the remaining genes are integrated into the genome through gene editing. At the same time, only a single antibiotic needs to be added. After induced culture for 16 hours, the blue pigment yield can reach a maximum of 10.25 g / L, which is significantly improved compared with the previous strains, and the production cost is reduced, which can further promote the industrial production process.

[0116] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A genetically engineered Escherichia coli for producing blue, characterized in that: The genetically engineered Escherichia coli bacteria are constructed by introducing the expression vector pRk-bpsA into the chassis strain; The expression vector pRk-bpsA is constructed by using pRK-bpsA-entD as a plasmid template, amplifying the bpsA fragment and the pRK plasmid skeleton by primer PCR, and then connecting the bpsA fragment and the pRK plasmid skeleton; The chassis strain is obtained by genetically modifying strain IN05, wherein the genetic modification includes knocking out the lactate dehydrogenase ldhA gene, the glutamate-5-kinase proB gene, and the pyruvate kinase pykF gene, and then integrating the phosphopantetheinyl transferase entD gene at the sites of the knocked-out lactate dehydrogenase ldhA gene and the glutamate-5-kinase proB gene, and integrating the glutamine synthetase glnA* gene with a point mutation at the site of the knocked-out pyruvate kinase pykF gene; the glutamine synthetase with a point mutation is a glutamine synthetase encoded by the glutamine synthetase glnA gene, wherein the 405th amino acid Y of the glutamine synthetase is mutated to any one of A, E, and F.

2. The genetically engineered Escherichia coli for producing blue as claimed in claim 1, characterized in that: The entD gene was first linked to the strong constitutive promoter J23119 before integration.

3. The method for constructing a genetically engineered Escherichia coli for producing blue as claimed in any one of claims 1 to 2, characterized in that: The steps include: (1) Based on strain IN05, the ldhA gene was knocked out using CRISPR-Cas9, and a strong constitutive promoter J23119-entD was introduced into the gene locus, named strain IN06; (2) Based on strain IN06, the proB gene was knocked out using CRISPR-Cas9, and a strong constitutive promoter J23119-entD was introduced into the gene locus, named strain IN07; (3) The glutamine synthetase glnA gene was amplified by PCR to introduce point mutations, and the gene fragments of glutamine synthetase glnA* with different mutations were obtained; 95S was used as a plasmid template, and the gene fragment glutamine synthetase glnA* was connected with the 95S linearized fragment to obtain 95S-glnA*; a strong constitutive promoter J23119-glnA* was introduced into the gene site; and the point mutation gene fragment J23119-glnA* was amplified with primers; (4) Based on strain IN07, the pykF gene was knocked out using CRISPR-Cas9, and the point mutation gene fragment J23119-glnA* obtained in step (3) was introduced into the gene site to obtain a chassis strain modified by point mutation; (5) Construction of expression vector pRK-bpsA: Using pRK-bpsA-entD plasmid as template, amplify the blue pigment synthase bpsA fragment and the pRK plasmid backbone by primer PCR, and then connect the bpsA fragment to the pRK plasmid backbone to obtain the expression vector pRK-bpsA; (6) The expression vector pRK-bpsA is transferred into the chassis strain obtained in step (4) after point mutation modification to construct an expression strain, thereby obtaining the genetically engineered Escherichia coli for producing blue.

4. Use of the genetically engineered Escherichia coli for producing indigo as claimed in any one of claims 1 to 2 in the production of indigo.

5. The use according to claim 4, characterized in that The production method is fermentation culture.

6. A method for producing indigo using the genetically engineered Escherichia coli bacteria for producing indigo according to any one of claims 1 to 2, characterized in that: The method comprises the following steps: inoculating the genetically engineered Escherichia coli bacteria used for producing indigo in a fermentation medium, adding antibiotics, and inducing culture to obtain a fermentation liquid containing indigo.

7. The method for producing a blue jellyfish according to claim 6, characterized in that: The inoculation amount of the genetically engineered Escherichia coli is 1-10%.

8. The method for producing a blue rayon according to claim 6, characterized in that: The fermentation medium is ZYM medium; the antibiotic is kanamycin.

9. The method for producing a blue jellyfish according to claim 6, characterized in that: The induction culture conditions are: temperature of 20-30°C, rotation speed of 180-225 rpm, and induction expression for 16-24 h.